drugset / Trial / NCT01165736

To Calculate the Pharmacokinetics (Concentration of Compound in and Rate of Excretion From the Blood) Following a Very Low Dose of Compound Which Will Not Have Any Pharmacological Activity

NCT01165736

Phase 1 Completed 40 enrolled Pfizer
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to calculate the pharmacokinetics (concentration of compound in and rate of excretion from the blood) following a very low dose of compound which will not have any pharmacological activity and to monitor for the safety and tolerability of each of the compounds in the study.

Timeline

Start
2010-07
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator PF-05089771 Small molecule 100 ug Intravenous
Comparator PF-05150122 Small molecule 100 ug Intravenous
Comparator PF-05186462 Small molecule 100 ug Intravenous
Comparator PF-05241328 Small molecule 100 ug Intravenous

Indications

No indication recorded.